美国 · 平台与数据 · MarketBeat
Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits
Edwards Lifesciences (NYSE:EW) highlighted new clinical data for its transcatheter tricuspid repair and transcatheter aortic valve replacement programs, including results from the…
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)



